cppd versus rheumatoid arthritis

Calcium pyrophosphate deposition disease (CPPD) and rheumatoid arthritis (RA) differ in pathogenesis, clinical presentation, joint involvement, progression, and management.

CPPD is characterized by deposition of calcium pyrophosphate crystals in joints, often manifesting radiographically as chondrocalcinosis, and it may be asymptomatic or associated with acute or chronic inflammatory arthritis. RA is a chronic systemic inflammatory autoimmune disease primarily affecting synovial joints with symmetrical involvement of small joints of the hands and feet NICE CKS Issa et al. 2025.

Clinically, RA presents with symmetrical inflammatory arthritis mainly affecting small joints with pain, swelling, heat, and early morning stiffness. It can lead to joint damage and systemic complications such as cardiovascular disease, osteoporosis, and anaemia NICE CKS. CPPD typically presents as acute or chronic arthritis with crystal-induced inflammation, often involving larger joints such as the knees and wrists, and is associated with features of osteoarthritis. CPPD can cause significant radiographic progression of arthritis especially after interventions like four-corner fusion Gullborg et al. 2026 Issa et al. 2025Gullborg et al. 2026.

Diagnosis of CPPD primarily relies on identification of calcium pyrophosphate crystals in synovial fluid and imaging showing chondrocalcinosis; there is no treatment currently able to dissolve CPP crystals, so management focuses on controlling inflammation Issa et al. 2025. Diagnosis of RA involves clinical assessment, serological tests, and specialist evaluation; early referral is important to initiate disease-modifying treatments, including conventional and biological DMARDs, aiming for remission or low disease activity NICE CKS.

CPPD is more strongly linked with older age and may be associated with increased cardiovascular risk profiles, although its coronary artery calcification burden is not significantly different from matched controls; RA is more common in middle-aged adults and disproportionately affects women NICE CKS Tedeschi et al. 2025.

In summary, CPPD and RA differ by:

• Pathophysiology: crystal deposition versus autoimmune synovitis NICE CKS,Issa et al. 2025
• Joint involvement: CPPD often involves larger joints; RA classically involves small joints symmetrically NICE CKS,Issa et al. 2025
• Systemic impact: RA has systemic complications; CPPD’s systemic associations are less well defined but includes CV risk NICE CKS,Tedeschi et al. 2025
• Radiographic features: chondrocalcinosis in CPPD; erosive changes and joint space narrowing in RA NICE CKS,Issa et al. 2025
• Treatment: inflammation control in CPPD with no crystal dissolution; immunomodulation in RA with DMARDs NICE CKS,Issa et al. 2025